Related Experiment Video
Updated: Sep 26, 2025
05:18
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
1.5K
Artificial intelligence supporting cancer patients across Europe-The ASCAPE project
Lazaros Tzelves1, Ioannis Manolitsis1, Ioannis Varkarakis1
1National and Kapodistrian University of Athens Faculty of Medicine Marousi, 2nd Department of Urology, Athens, Greece.
Plos One
|April 21, 2022
Summary
The ASCAPE project uses artificial intelligence (AI) to predict quality of life (QoL) issues for breast and prostate cancer survivors, offering personalized interventions to improve their care and rehabilitation.
Area of Science:
- Oncology
- Artificial Intelligence in Healthcare
- Digital Health
Background:
- Cancer survivors, particularly those of breast and prostate cancer, frequently experience diminished quality of life (QoL).
- Current support strategies for impaired QoL in cancer survivors are often insufficient, leaving critical patient needs unmet.
- There is a need for advanced, individualized approaches to cancer rehabilitation and survivorship care.
Purpose of the Study:
- To develop and evaluate a personalized, AI-driven platform (ASCAPE) for predicting QoL issues in breast and prostate cancer patients.
- To provide physicians with AI-generated intervention suggestions for improved cancer rehabilitation.
- To enhance the holistic care and QoL for cancer survivors through innovative technology.
Main Methods:
- Development of an AI-based platform integrating data from medical records, questionnaires, apps, and wearables.
- Prospective, longitudinal evaluation of the AI platform with breast and prostate cancer survivors across four European study sites.
- Assessment of patient-reported outcomes, engagement, QoL improvements, and clinician perspectives on platform impact.
Main Results:
- The ASCAPE project is the first to prospectively investigate an AI-based approach for individualized follow-up focusing on QoL issues in cancer survivors.
- The platform aims to facilitate a paradigm shift towards personalized follow-up strategies addressing unmet QoL needs.
- The study will provide insights into the utility of Big Data and AI in cancer care and rehabilitation.
Conclusions:
- ASCAPE offers a novel, AI-powered solution to address the unmet QoL needs of breast and prostate cancer survivors.
- The project pioneers an individualized follow-up strategy leveraging AI and Big Data for enhanced cancer rehabilitation.
- This approach promises to democratize access to AI innovations in cancer care, improving patient outcomes and physician support.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:43Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K